Nontuberculous mycobacteria

Timothy Aksamit, David E. Griffith

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The nontuberculous mycobacteria (NTM) are ubiquitous in the environment; so much so that some experts feel they should be referred to as “environmental mycobacteria.” Although there are more than 120 identified NTM species, the most common NTM associated with human disease are Mycobacterium avium complex (MAC), Mycobacterium kansasii, Mycobacterium fortuitum, and Mycobacterium abscessus. Many other NTM species can cause human disease but are generally rarely encountered clinically, whereas a few NTM species, most notably Mycobacterium gordonae, are frequently isolated as specimen contaminants and almost never cause disease. Infection is thought to occur from environmental exposure to the NTM with three potential portals of entry; the respiratory tract, the gastrointestinal tract, and direct inoculation of the skin and soft tissues. There are no documented occurrences of either human-to-human or animal-to-human transmission. The most common clinical manifestation of NTM infection in the immunocompetent host is chronic pulmonary disease. Symptoms are usually insidious in onset and include cough, sputum production, fatigue, weight loss, weakness, hemoptysis, and night sweats. MAC is the most common respiratory pathogen. Patients with MAC lung disease are divided between two groups. The first are primarily female patients without a history of pre-existing lung disease who have noncavitary disease characterized by nodular densities and bronchiectasis, usually in the right middle lobe and lingua. The second group are primarily male patients with pre-existing lung disease, most often chronic obstructive lung disease, and cavitary abnormalities radiographically, similar to tuberculosis.

Original languageEnglish (US)
Title of host publicationClinical Infectious Disease
PublisherCambridge University Press
Pages1087-1094
Number of pages8
ISBN (Electronic)9780511722240
ISBN (Print)9780521871129
DOIs
StatePublished - Jan 1 2010

Fingerprint

Nontuberculous Mycobacteria
Mycobacterium avium Complex
Lung Diseases
Preexisting Condition Coverage
Mycobacterium
Nontuberculous Mycobacterium Infections
Mycobacterium kansasii
Mycobacterium fortuitum
Bronchiectasis
Hemoptysis
Sweat
Environmental Exposure
Sputum
Cough
Respiratory System
Chronic Obstructive Pulmonary Disease
Fatigue
Gastrointestinal Tract
Weight Loss
Tuberculosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aksamit, T., & Griffith, D. E. (2010). Nontuberculous mycobacteria. In Clinical Infectious Disease (pp. 1087-1094). Cambridge University Press. https://doi.org/10.1017/CBO9780511722240.157

Nontuberculous mycobacteria. / Aksamit, Timothy; Griffith, David E.

Clinical Infectious Disease. Cambridge University Press, 2010. p. 1087-1094.

Research output: Chapter in Book/Report/Conference proceedingChapter

Aksamit, T & Griffith, DE 2010, Nontuberculous mycobacteria. in Clinical Infectious Disease. Cambridge University Press, pp. 1087-1094. https://doi.org/10.1017/CBO9780511722240.157
Aksamit T, Griffith DE. Nontuberculous mycobacteria. In Clinical Infectious Disease. Cambridge University Press. 2010. p. 1087-1094 https://doi.org/10.1017/CBO9780511722240.157
Aksamit, Timothy ; Griffith, David E. / Nontuberculous mycobacteria. Clinical Infectious Disease. Cambridge University Press, 2010. pp. 1087-1094
@inbook{f3344f5433ff4f5b8e243c26182848bd,
title = "Nontuberculous mycobacteria",
abstract = "The nontuberculous mycobacteria (NTM) are ubiquitous in the environment; so much so that some experts feel they should be referred to as “environmental mycobacteria.” Although there are more than 120 identified NTM species, the most common NTM associated with human disease are Mycobacterium avium complex (MAC), Mycobacterium kansasii, Mycobacterium fortuitum, and Mycobacterium abscessus. Many other NTM species can cause human disease but are generally rarely encountered clinically, whereas a few NTM species, most notably Mycobacterium gordonae, are frequently isolated as specimen contaminants and almost never cause disease. Infection is thought to occur from environmental exposure to the NTM with three potential portals of entry; the respiratory tract, the gastrointestinal tract, and direct inoculation of the skin and soft tissues. There are no documented occurrences of either human-to-human or animal-to-human transmission. The most common clinical manifestation of NTM infection in the immunocompetent host is chronic pulmonary disease. Symptoms are usually insidious in onset and include cough, sputum production, fatigue, weight loss, weakness, hemoptysis, and night sweats. MAC is the most common respiratory pathogen. Patients with MAC lung disease are divided between two groups. The first are primarily female patients without a history of pre-existing lung disease who have noncavitary disease characterized by nodular densities and bronchiectasis, usually in the right middle lobe and lingua. The second group are primarily male patients with pre-existing lung disease, most often chronic obstructive lung disease, and cavitary abnormalities radiographically, similar to tuberculosis.",
author = "Timothy Aksamit and Griffith, {David E.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9780511722240.157",
language = "English (US)",
isbn = "9780521871129",
pages = "1087--1094",
booktitle = "Clinical Infectious Disease",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Nontuberculous mycobacteria

AU - Aksamit, Timothy

AU - Griffith, David E.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The nontuberculous mycobacteria (NTM) are ubiquitous in the environment; so much so that some experts feel they should be referred to as “environmental mycobacteria.” Although there are more than 120 identified NTM species, the most common NTM associated with human disease are Mycobacterium avium complex (MAC), Mycobacterium kansasii, Mycobacterium fortuitum, and Mycobacterium abscessus. Many other NTM species can cause human disease but are generally rarely encountered clinically, whereas a few NTM species, most notably Mycobacterium gordonae, are frequently isolated as specimen contaminants and almost never cause disease. Infection is thought to occur from environmental exposure to the NTM with three potential portals of entry; the respiratory tract, the gastrointestinal tract, and direct inoculation of the skin and soft tissues. There are no documented occurrences of either human-to-human or animal-to-human transmission. The most common clinical manifestation of NTM infection in the immunocompetent host is chronic pulmonary disease. Symptoms are usually insidious in onset and include cough, sputum production, fatigue, weight loss, weakness, hemoptysis, and night sweats. MAC is the most common respiratory pathogen. Patients with MAC lung disease are divided between two groups. The first are primarily female patients without a history of pre-existing lung disease who have noncavitary disease characterized by nodular densities and bronchiectasis, usually in the right middle lobe and lingua. The second group are primarily male patients with pre-existing lung disease, most often chronic obstructive lung disease, and cavitary abnormalities radiographically, similar to tuberculosis.

AB - The nontuberculous mycobacteria (NTM) are ubiquitous in the environment; so much so that some experts feel they should be referred to as “environmental mycobacteria.” Although there are more than 120 identified NTM species, the most common NTM associated with human disease are Mycobacterium avium complex (MAC), Mycobacterium kansasii, Mycobacterium fortuitum, and Mycobacterium abscessus. Many other NTM species can cause human disease but are generally rarely encountered clinically, whereas a few NTM species, most notably Mycobacterium gordonae, are frequently isolated as specimen contaminants and almost never cause disease. Infection is thought to occur from environmental exposure to the NTM with three potential portals of entry; the respiratory tract, the gastrointestinal tract, and direct inoculation of the skin and soft tissues. There are no documented occurrences of either human-to-human or animal-to-human transmission. The most common clinical manifestation of NTM infection in the immunocompetent host is chronic pulmonary disease. Symptoms are usually insidious in onset and include cough, sputum production, fatigue, weight loss, weakness, hemoptysis, and night sweats. MAC is the most common respiratory pathogen. Patients with MAC lung disease are divided between two groups. The first are primarily female patients without a history of pre-existing lung disease who have noncavitary disease characterized by nodular densities and bronchiectasis, usually in the right middle lobe and lingua. The second group are primarily male patients with pre-existing lung disease, most often chronic obstructive lung disease, and cavitary abnormalities radiographically, similar to tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=84923398655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923398655&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511722240.157

DO - 10.1017/CBO9780511722240.157

M3 - Chapter

SN - 9780521871129

SP - 1087

EP - 1094

BT - Clinical Infectious Disease

PB - Cambridge University Press

ER -